OTC · CTTH
CTT Pharmaceutical Holdings, Inc.
$0.06+$0.01 (+11.98%)
CTT Pharmaceutical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.1% below the high.
Loading market information…
OTC · HBRM · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Herborium Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Herborium Group, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Herborium Group, Inc. operates as a specialized firm in botanical therapeutics, focusing on the creation, licensing, and commercialization of its unique, plant-based medicinal goods for both general consumers and healthcare professionals. Its product range includes dermatological solutions like AcnEase, an herbal treatment designed to alleviate symptoms associated with hormonal acne and various forms of Rosacea. The company also offers the AcnEase Skin Management System, intended to diminish acne marks and scars. Furthermore, Herborium provides non-prescription sexual health and performance products. These serve as alternatives for specific sexual dysfunctions that may arise from cardiovascular conditions, the use of antidepressants, or surgical procedures such as hysterectomies. The company also offers energy-boosting products, notably Lasting Energy. This herbal supplement aims to reduce hangover effects, counteract jet lag, and address general energy depletion caused by intense physical activities, high stress levels, prolonged sexual engagements, or other enduring or temporary physical demands. Additional products in its portfolio include the Liver Activator Series for managing liver damage; ProstAid, a natural remedy specifically formulated for Benign Prostate Hyperplasia (BPH); and CardioVitae, a fermentation-based product utilizing a Lucidium-derived cell line to target cardio-pulmonary insufficiencies. Herborium Group, Inc. distributes its products across the United States, the United Kingdom, and mainland Europe, utilizing a network of distributors, specialty retailers, and its e-commerce platform. The company was founded in 2000 and has its principal office located in Fort Lee, New Jersey.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:21 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.06+$0.01 (+11.98%)
CTT Pharmaceutical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.1% below the high.
$0.03-$0.00 (0.0%)
Bionoid Pharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.3% below the high.
$0.18$0.00 (0.0%)
Procyon Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
$0.00-$0.00 (-25.0%)
Medical Marijuana, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.5% below the high.
$0.00$0.00 (0.0%)
Yooma Wellness Inc’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Endexx Corporation’s quoted price sits in the lower half of its reported 52-week range, 99.75% below the high.
$0.00$0.00 (0.0%)
BioTech Medics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.65% below the high.
$0.00$0.00 (0.0%)
Body and Mind Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
